![Jude Onyia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jude Onyia
Chief Tech/Sci/R&D Officer at
NEUROCRINE BIOSCIENCES, INC.
Net worth: 4 M $ as of 2026-05-30
Profile
Jude Onyia currently works at Voyager Therapeutics, Inc., as Director from 2023 and Neurocrine Biosciences, Inc., as Chief Scientific Officer from 2021.
Dr. Onyia also formerly worked at Eli Lilly & Co., as Vice President-Biotechnology Discovery Research from 2014 to 2021 and Capsida Biotherapeutics, Inc., as Chief Scientific Officer in 2021.
Dr. Onyia received his doctorate degree from State University of New York at Downstate Medical Center, undergraduate degree from Suny College of Environmental Science & Forestry, and doctorate degree from SUNY Upstate Medical University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-04 | 23,405 ( 0.02% ) | 4 M $ | 2026-05-30 | |
| 2026-06-08 | 2,910 ( 0% ) | 11 262 $ | 2026-05-30 |
Jude Onyia active positions
| Companies | Position | Start |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-11-29 |
| VOYAGER THERAPEUTICS, INC. | Director/Board Member | 2023-02-20 |
Former positions of Jude Onyia
| Companies | Position | End |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Chief Tech/Sci/R&D Officer | 2021-10-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2021-05-31 |
Training of Jude Onyia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
SUNY College of Environmental Science
 SUNY College of Environmental Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
- Stock Market
- Insiders
- Jude Onyia
